OTLC
Oncotelic Therapeutics, Inc. · Healthcare · Market cap $5.9M
Insiders bought $24K net in the last 90 days ·0 sellers, 1 buyer· latest Form 4 filed Oct 30, 2026
Insider Buying
$61K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Latest filing
Oct 30, 2026
Trieu Vuong
Oncotelic Therapeutics, Inc. (OTLC) has 5 SEC Form 4 filings (9 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Oct 30, 2026.
Inside the rolling window, 2 insiders at Oncotelic Therapeutics, Inc. reported 9 open-market purchases totaling $61K and no open-market sales. The most active filer is CHAIRMAN AND CEO Trieu Vuong with 8 filings. The most recent open-market filing is a purchase of 1,044,990 shares by CHAIRMAN AND CEO Trieu Vuong, dated Oct 29, 2026, worth $18K.
- Industry:Biotechnology
- CEO:Vuong Trieu
- Employees:41
- HQ:Agoura Hills, CA, US
- IPO:1993-08-26
| Source | |||||||
|---|---|---|---|---|---|---|---|
Trieu VuongFirst in 4 months | CHAIRMAN AND CEO | Purchase | 1,044,990 | $18K | Oct 30 | -21.8% | SEC ↗ |
Trieu VuongFirst in 4 months | CHAIRMAN AND CEO | Purchase | 312,000 | $6K | Oct 30 | -21.8% | SEC ↗ |
| CHAIRMAN AND CEO | Purchase | 240,000 | $10K | Jul 2 | -67.7% | SEC ↗ | |
| CHAIRMAN AND CEO | Purchase | 115,000 | $5K | Jun 25 | -67.7% | SEC ↗ | |
| CHAIRMAN AND CEO | Purchase | 75,000 | $3K | Jun 25 | -67.7% | SEC ↗ | |
| CHAIRMAN AND CEO | Purchase | 65,000 | $3K | Jun 25 | -67.7% | SEC ↗ | |
Shah Amit B.First filing | CFO | Purchase | 20,000 | $1K | Jun 22 | -74.2% | SEC ↗ |
Trieu VuongFirst filing | CHAIRMAN AND CEO | Purchase | 239,759 | $11K | Jun 17 | -74.2% | SEC ↗ |
Trieu VuongFirst filing | CHAIRMAN AND CEO | Purchase | 96,000 | $4K | Jun 17 | -74.2% | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does OTLC have?
Oncotelic Therapeutics, Inc. (OTLC) has 5 SEC Form 4 filings (9 transaction rows) in the rolling 365-day window, disclosed by 2 distinct insiders. Most recent filing: Oct 30, 2026.
When was the most recent SEC Form 4 filing for OTLC?
The most recent Form 4 filing for OTLC on Tracefour is dated Oct 30, 2026.
Who is the most active insider at OTLC?
The most active SEC Form 4 filer at OTLC in the rolling window is CHAIRMAN AND CEO Trieu Vuong, with 8 filings.
What is the net insider flow at OTLC over the last 6 months?
Over the trailing 180 days, insiders at OTLC have net bought $61K based on SEC Form 4 disclosures.
What is the total insider buy and sell value at OTLC in the current window?
Inside the rolling window, insiders at OTLC bought $61K and sold $0 based on SEC Form 4 filings.
Can I get alerts for OTLC insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at Oncotelic Therapeutics, Inc. (OTLC). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
Oncotelic Therapeutics, Inc. is in the Healthcare sector.